Global Health Limited

IPO Size


Price Band


Minimum Lot Size


Face Value

`2 Per Share

Employee Discount


Retail Allocation


Issue Open Date


Issue Close Date


Listing Date


About the Company:

As per the reports of Crisil, global Health is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.


Under the “Medanta” brand, global health has a network of four hospitals currently in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital which is under construction with an operational outpatient facility (Patna), and one hospital (Noida) planned for development. As of March 31, 2021, the firm provides healthcare services in over 30 medical specialties and engages over 1,100 doctors led by highly experienced department heads and, spanning an area of 3.7 million sq. ft., our operational hospitals have 2,176 installed beds.

Outstanding Litigation:

S.No. 1 - Company 2 - Directors 3 - Promoters
Entity Name By the Company Against the Company By the Director Against the Director By the Promoter Against the Promoter
Criminal cases 1 3 - - - 1
Material civil cases 1 14 - - - -
Taxation matters - - - - - -
Regulatory Proceedings - - - - - -

Financial Statements:

Income Statement(in Millions) March'2021 March'2020 March'2019
Gross Operating Income 14,781.58 15,442.67 15,059.87
Cost of Employee & Inventory 4,663.36 5,387.81 5,410.80
Other Expenses 12,553.06 13,137.91 12,680.69
Finance Cost 671.74 515.47 530.50
Depreciation 1,232.14 1,150.40 1,016.00
Profit Before Tax  324.64 638.87 832.42
 Tax 36.59 275.60 319.39
Profit After Tax 288.05 363.27 513.03

Promoter of the Company

DR. Naresh Trehan

Peer Comparison

• Apollo Hospitals Enterprise Limited • Fortis healthcare limited • Max healthcare enterprise Limited • Narayana Hrudalaya Limited

Objectives of the Issue

Offer for Sale

Proceeds from the Offer for sale, cumulative sale of 4.84 crore equity shares

Fresh Issue

Net proceed of Rs500cr from the offer for sale will be utilized for the following: • Repayment/prepayment of borrowings, in full or part, of our Subsidiaries, GHPPL and MHPL; and • . General corporate purposes

Download the App

Get best experience

Download Now